5-(Pyridin-3-yl)isoxazole-3-carboxylic acid, 95.0%, 100mg

((1-(tert-Butoxycarbonyl)piperidin-4-yl)methyl)triphenylphosphonium iodide, 95%, 100mg

Ácido 4-hidrazinabenzoico, mínimo 97 %, para síntesis, 50 g, envase de vidrio

2-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)aniline, 95%, 1g

(S)-1-Amino-1-(4-fluorophenyl)-2-methylpropan-2-ol, 98%, 1g

2-Chloro-6-methylbenzoic Acid>98.0%(GC)(T)5g

(S)-2-amino-3-(4-methoxy-3-methylphenyl)propanoic acid, 95%, 1g

Diethyl Diisobutylmalonate>98.0%(GC)25mL

Benzo[d]isothiazole-3(2H)-thione 1,1-dioxide, 95.0%, 250mg

4-Hydroxy-4-methylpiperidine-1-carboxylic acid benzyl ester, 95.0%, 1g

Sorbitan monopalmitate, Saponification Value 145-155, 100g

6-Bromo-5-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 97%, 250mg

2-Benzylsuccinic acid, 95.0%, 250mg